Dermatology Research Associate

Los Angeles, California 90045

0 studies enrolling now · 6 studies all time

What they study most

Atopic Dermatitis, Atopic Dermatitis Eczema, Basal Cell Carcinoma, Urticaria

Studies at this site

• A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis — Completed
• A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria — Completed
• A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis — Completed
• A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas — Completed
• An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC) — Stopped early